BECN1 and chronic myelogenous leukemia, BCR-ABL1 positive: Inhibitors such as bafilomycin A1 (baf-A1) and siRNA against beclin 1 abrogated autophagy, sensitized CML cells against TMQ0153 and enhanced necroptotic cell death.